View : 159 Download: 0

Alleviation of Atopic Dermatitis Lesions by a Benzylideneacetophenone Derivative via the MAPK Signaling Pathway

Title
Alleviation of Atopic Dermatitis Lesions by a Benzylideneacetophenone Derivative via the MAPK Signaling Pathway
Authors
Sur, BongjunKang, SeungminKim, MijinOh, Seikwan
Ewha Authors
오세관서봉준
SCOPUS Author ID
오세관scopus
Issue Date
2019
Journal Title
INFLAMMATION
ISSN
0360-3997JCR Link

1573-2576JCR Link
Citation
INFLAMMATION vol. 42, no. 3, pp. 1093 - 1102
Keywords
atopic dermatitisbenzylideneacetophenone derivativetrimellitic anhydrideinterleukin-4mitogen-activated protein kinase
Publisher
SPRINGER/PLENUM PUBLISHERS
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
This experiment was conducted to investigate the effects of a benzylideneacetophenone derivative ((2E)-3-(4-hydroxy-3-methoxyphenyl)phenylpro-2-en-l-one (JC3)) on trimellitic anhydride (TMA)-induced atopic dermatitis (AD)-like symptoms in mice. To induce AD, the dorsal skins of mice were treated with 5% TMA on day 0 and both ears were treated with 5% TMA on day 5 and with 2% TMA from day 6 to day 14. JC3 (1, 5, 10mg/kg, i.p.) was treated once daily from day 9 to day 14 before TMA treatment. Histological analysis was performed and auricular lymph node weights, ear thicknesses, skin water contents, scratching behaviors, and serum immunoglobulin (IgE) and IFN-, and interleukin-4 (IL-4) levels in serum and ear tissues were determined. In addition, the anti-AD activity of JC3 was investigated on phorbol 12-myristate 13-acetate (PMA)-stimulated human mast cells (HMC-1 cells) derived from patients. Levels of TNF-, IL-4, and mitogen-activated protein kinase (MAPK) were investigated after treating cultured cells with JC3. Treating mice with JC3 (10mg/kg) significantly decreased ear thicknesses, lymph node weights, skin scores, skin water contents, scratching behavior, and IFN-, IL-4 cytokine levels, and serum IgE levels. Moreover, treatment with JC3 (10mg/kg) significantly decreased serum and ear tissues levels of IFN- and IL-4 in AD mice. Furthermore, treatment with JC3 at 10g/ml reduced TNF- and IL-4 levels and decreased MAPK phosphorylation in the HMC-1 cells. The results of this study provide a molecular basis for developing new therapeutics for the treatment of various inflammatory diseases, such as, eczema, asthma, and AD.
DOI
10.1007/s10753-019-00971-w
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE